病毒样粒子 (VLP) 疫苗用于癌症免疫疗法
Francesca Ruzzi1, Maria Sofia Semprini1, Laura Scalambra1
1Department of Medical and Surgical Sciences (DIMEC) and Alma Mater Institute on Healthy Planet, University of Bologna, 40126 Bologna, Italy.
International journal of molecular sciences
|August 26, 2023
概括
病毒样粒子 (VLP) 疫苗在预防和治疗癌症方面表现有前途. 本综述涵盖已批准的VLP疫苗和基于VLP的癌症疫苗的新兴数据,包括针对HER-2-阳性乳腺癌的疫苗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 癌症疫苗是预防和治疗癌症的日益增长的研究领域.
- 虽然已经建立了针对病毒相关癌症的预防性疫苗,但治疗性癌症疫苗的开发需要进一步推进.
- 病毒样颗粒 (VLPs) 是强大的疫苗平台,模仿病毒结构以引起强烈的免疫反应.
研究的目的:
- 对HBV和HPV感染的已批准的基于VLP的预防性疫苗进行审查.
- 总结关于基于VLP的疫苗用于预防病毒引起的癌症的数据.
- 介绍基于VLP的预防和治疗癌症疫苗的临床前和早期临床发现,重点是HER-2-阳性乳腺癌.
主要方法:
- 对已批准的VLP疫苗进行文献审查.
- 对基于VLP的癌症疫苗的临床前和早期临床试验数据的分析.
- 专注于用于抗原显示和免疫刺激的VLP平台技术.
主要成果:
- 几种基于VLP的疫苗已被批准用于预防HBV和HPV感染.
- VLP平台有效地显示抗原,诱导强大的细胞和幽默免疫力.
- 新出现的数据表明,基于VLP的疫苗在预防性和治疗性癌症环境中都有潜力,包括HER-2-阳性乳腺癌.
结论:
- VLP技术为开发有效的癌症疫苗提供了一个多功能平台.
- 需要进一步的研究和临床试验,以优化基于VLP的癌症疫苗用于治疗应用.
- VLP疫苗具有改善癌症预防和治疗策略的巨大潜力.
相关概念视频
Cancer Vaccines
400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Rous Sarcoma Virus (RSV) and Cancer
5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.1K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


